Telomerase activity in small cell esophageal carcinoma

被引:18
作者
Chow, V
Law, S
Lam, KY
Luk, JM
Wong, J [1 ]
机构
[1] Univ Hong Kong, Med Ctr, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Med Ctr, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1046/j.1442-2050.2001.00172.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Small cell carcinoma of the esophagus is a rare and aggressive malignant tumor. Telomerase activation is common in human cancers. There is a lack of data on telomerase activity in esophageal small cell cancers. The present report studied the role of telomerase activity in esophageal small cell carcinoma. The clinicopathologic data of five patients with small cell carcinoma of the esophagus who underwent primary surgical treatment between 1991 and 2000 were studied. Telomeric repeat amplification protocol assays were used to investigate telomerase activity in these tumors. The proliferative activity (MIB-1) and p53 expression of these tumors were also studied using immunohistochemistry and correlated with the telomerase activity. All five small cell carcinomas showed detectable telomerase activity in the primary tumor. Two out of the five morphologically normal esophageal mucosae adjacent to the primary tumor had detectable telomerase activity. There was no correlation between the p53 expression, tumor stage, survival of patients, and the presence of telomerase activity. High MIB-1 expression in esophageal small cell carcinomas was associated with high telomerase activity. Telomerase activation is common in small cell carcinoma of the esophagus. This fact may find application in anti-telomerase treatment for this aggressive tumor.
引用
收藏
页码:139 / 142
页数:4
相关论文
共 26 条
[1]  
Asai A, 1998, ANTICANCER RES, V18, P1465
[2]   Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions [J].
Bachor, C ;
Bachor, OA ;
Boukamp, P .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (8-9) :453-460
[3]   THE RNA COMPONENT OF HUMAN TELOMERASE [J].
FENG, JL ;
FUNK, WD ;
WANG, SS ;
WEINRICH, SL ;
AVILION, AA ;
CHIU, CP ;
ADAMS, RR ;
CHANG, E ;
ALLSOPP, RC ;
YU, JH ;
LE, SY ;
WEST, MD ;
HARLEY, CB ;
ANDREWS, WH ;
GREIDER, CW ;
VILLEPONTEAU, B .
SCIENCE, 1995, 269 (5228) :1236-1241
[4]   Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides [J].
Glukhov, AI ;
Zimnik, OV ;
Gordeev, SA ;
Severin, SE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (02) :368-371
[5]   Detection of telomerase activity in esophageal squamous cell carcinoma and normal esophageal epithelium [J].
Ikeguchi, M ;
Unate, H ;
Maeta, M ;
Kaibara, N .
LANGENBECKS ARCHIVES OF SURGERY, 1999, 384 (06) :550-555
[6]   SPECIFIC ASSOCIATION OF HUMAN TELOMERASE ACTIVITY WITH IMMORTAL CELLS AND CANCER [J].
KIM, NW ;
PIATYSZEK, MA ;
PROWSE, KR ;
HARLEY, CB ;
WEST, MD ;
HO, PLC ;
COVIELLO, GM ;
WRIGHT, WE ;
WEINRICH, SL ;
SHAY, JW .
SCIENCE, 1994, 266 (5193) :2011-2015
[7]   Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation [J].
Kondo, S ;
Tanaka, Y ;
Kondo, Y ;
Hitomi, M ;
Barnett, GH ;
Ishizaka, Y ;
Liu, J ;
Haqqi, T ;
Nishiyama, A ;
Villeponteau, B ;
Cowell, JK ;
Barna, BP .
FASEB JOURNAL, 1998, 12 (10) :801-811
[8]   Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA [J].
Kondo, S ;
Kondo, Y ;
Li, GY ;
Silverman, RH ;
Cowell, JK .
ONCOGENE, 1998, 16 (25) :3323-3330
[9]   Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis [J].
Kondo, Y ;
Kondo, S ;
Tanaka, Y ;
Haqqi, T ;
Barna, BP ;
Cowell, JK .
ONCOGENE, 1998, 16 (17) :2243-2248
[10]   Clinical significance of telomerase activity in the non-cancerous epithelial region of oesophageal squamous cell carcinoma [J].
Koyanagi, K ;
Ozawa, S ;
Ando, N ;
Takeuchi, H ;
Ueda, M ;
Kitajima, M .
BRITISH JOURNAL OF SURGERY, 1999, 86 (05) :674-679